What does C-Bridge Capital invest in?
C-Bridge Capital invests most often at Series B and Series A (80% of the rounds on record).
United States · Investor
No cheque observed since Jun 2018, after 6 earlier cheques, and the website is dead.
DormantGrowth equity
6 rounds on record
Mostly Series B and Series A: 80% of its rounds
Sole investor in 3 rounds, median $25M
Every round we can evidence, newest first6 appearances
1 round
3 rounds
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The latest companies C-Bridge Capital put money into.
C-Bridge Capital invests most often at Series B and Series A (80% of the rounds on record).
6 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2018.
Its most recent investments on record: Nuance Biotech (Series B, Jun 2018), Anrei Medical (Undisclosed round, Jan 2017) and Ascletis (Series B, Jan 2017).
The median round it joins is $32M.
Rarely, if at all: none of its 6 investments on record names it as the lead.
Most of the companies it backs are in China (67%) and the United States (33%).
It looks quiet: no investment on record since Jun 2018.
C-Bridge Capital is a growth equity firm based in United States.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it